Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange ProgramM. John Gill, Volkan Korten, Ladislav Machala et al.|Clinical Infectious Diseases|2012Cited by 208
Amyloid and tau cerebrospinal fluid biomarkers in HIV infectionMagnus Gisslén, Henrik Zetterberg, Jan Jessen Krut et al.|BMC Neurology|2009Cited by 149
CSF neurofilament protein (NFL) — a marker of active HIV-related neurodegenerationSahra Abdulle, Magnus Gisslén, Åsa Mellgren et al.|Journal of Neurology|2007Cited by 132
Elevated Cerebrospinal Fluid Neurofilament Light Protein Concentrations Predict the Development of AIDS Dementia ComplexMagnus Gisslén, Lars Rosengren, Lars Hagberg et al.|The Journal of Infectious Diseases|2007Cited by 122
Defining and Evaluating HIV-Related Neurodegenerative Disease and Its Treatment Targets: A Combinatorial Approach to Use of Cerebrospinal Fluid Molecular BiomarkersMagnus Gisslén, Richard W. Price, Lars Hagberg et al.|Journal of Neuroimmune Pharmacology|2006Cited by 48